Views Day | Week | Month
Advanced Search
OTHER CALENDARS
- Academic Calendars
- Homecoming, Reunion &
Family Weekend
- Schools & Departments
- New Orleans Arts | Music
SPONSOR RESOURCES
.
Department of Pharmacology Fall Seminar Series
Targetting the Blood-Brain Barrier in Brain Tumors
featuring Edward A. Neuwelt, MD
Date: Friday, October 11, 2013
Time: 12:00 PM - 12:00 PM
Building: 1430 Tulane Avenue (Medicine) in Room 4700
Location: downtown campus
Background
Edward A. Neuwelt, M.D. is a Professor in the Departments of Neurology and Neurosurgery at Oregon Health & Science University and the Portland Veterans Affairs Medical Center in Portland, Oregon. He divides his time between clinical work, primarily in the area of neuro-oncology including both operative neurosurgery and chemotherapy, and directing his research laboratory.
Research Interests
The OHSU Blood-Brain Barrier and Neuro-Oncology Program conducts innovative patient-oriented research in all aspects of imaging and therapy of brain tumors. Dr. Neuwelt’s research interests have centered around the blood-brain barrier (BBB) and brain tumor therapy. In his initial VA Merit Review grant in 1978, Dr. Neuwelt predicted that manipulation of the BBB with transient osmotic shrinkage had the potential for a therapeutic role in brain tumor therapy. This hypothesis has been verified (Kraemer 2001), and the BBB disruption technique is now central to the preclinical and clinical research studies in the Neuwelt laboratory. Overall, Dr. Neuwelt’s research interests have centered around improving brain tumor therapy, reducing chemotherapy side effects, and improving brain tumor imaging. Dr. Neuwelt currently has a VA Merit review grant, three NIH research grants, an R13 NIH meeting grant, and is a member of a DOD breast cancer Center of Excellence.
Cancers in the brain are difficult to treat because of neurotoxicity, tumor resistance, and minimal delivery of potential therapies across the blood-brain barrier. We do basic science and preclinical studies of new approaches to delivery, treatment, and imaging in primary and metastatic brain tumor models.
For more information on Dr. Neuwelt, please click the link here.
Sponsored by: Pharmacology Department
Admission: Free
Attendance: See description
Open to: Alumni, Faculty, Graduate students, Undergraduates, Visitors
For more information
contact Sewann Strong
via
email to sstrong@tulane.edu
or by
phone at 504-988-5444
Date: Friday, October 11, 2013
Time: 12:00 PM - 12:00 PM
Building: 1430 Tulane Avenue (Medicine) in Room 4700
Location: downtown campus
Background
Edward A. Neuwelt, M.D. is a Professor in the Departments of Neurology and Neurosurgery at Oregon Health & Science University and the Portland Veterans Affairs Medical Center in Portland, Oregon. He divides his time between clinical work, primarily in the area of neuro-oncology including both operative neurosurgery and chemotherapy, and directing his research laboratory.
Research Interests
The OHSU Blood-Brain Barrier and Neuro-Oncology Program conducts innovative patient-oriented research in all aspects of imaging and therapy of brain tumors. Dr. Neuwelt’s research interests have centered around the blood-brain barrier (BBB) and brain tumor therapy. In his initial VA Merit Review grant in 1978, Dr. Neuwelt predicted that manipulation of the BBB with transient osmotic shrinkage had the potential for a therapeutic role in brain tumor therapy. This hypothesis has been verified (Kraemer 2001), and the BBB disruption technique is now central to the preclinical and clinical research studies in the Neuwelt laboratory. Overall, Dr. Neuwelt’s research interests have centered around improving brain tumor therapy, reducing chemotherapy side effects, and improving brain tumor imaging. Dr. Neuwelt currently has a VA Merit review grant, three NIH research grants, an R13 NIH meeting grant, and is a member of a DOD breast cancer Center of Excellence.
Cancers in the brain are difficult to treat because of neurotoxicity, tumor resistance, and minimal delivery of potential therapies across the blood-brain barrier. We do basic science and preclinical studies of new approaches to delivery, treatment, and imaging in primary and metastatic brain tumor models.
Sponsored by: Pharmacology Department
Admission: Free
Attendance: See description
Open to: Alumni, Faculty, Graduate students, Undergraduates, Visitors
For more information contact Sewann Strong via email to sstrong@tulane.edu or by phone at 504-988-5444
Calendar of Events, Tulane University 504-865-5000 calendar@tulane.edu